Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Are climate change and air pollution triggering cardiovascular disease?
Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...
A Modification to Homeopathic Drug Carcinosin
Cancer is linked to genetic mutations in hosts who are already genetically unique, which can make it seem...
Do human activities increase antibiotic-resistant disease in Chilean penguins?
Penguins are suffering population declines due to a variety of human causes, including disease. One indicator...